Product Details for NDA 018021
ASENDIN (AMOXAPINE)
25MG
Marketing Status: Discontinued
50MG
Marketing Status: Discontinued
100MG
Marketing Status: Discontinued
150MG
Marketing Status: Discontinued
25MG
Marketing Status: Discontinued
Active Ingredient: AMOXAPINE
Proprietary Name: ASENDIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N018021
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: LEDERLE LABORATORIES DIV AMERICAN CYANAMID CO
Marketing Status: Discontinued
Patent and Exclusivity Information
ASENDIN (AMOXAPINE)
Proprietary Name: ASENDIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N018021
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: LEDERLE LABORATORIES DIV AMERICAN CYANAMID CO
Marketing Status: Discontinued
Patent and Exclusivity Information
50MG
Marketing Status: Discontinued
Active Ingredient: AMOXAPINE
Proprietary Name: ASENDIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 50MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N018021
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: LEDERLE LABORATORIES DIV AMERICAN CYANAMID CO
Marketing Status: Discontinued
Patent and Exclusivity Information
ASENDIN (AMOXAPINE)
Proprietary Name: ASENDIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 50MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N018021
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: LEDERLE LABORATORIES DIV AMERICAN CYANAMID CO
Marketing Status: Discontinued
Patent and Exclusivity Information
100MG
Marketing Status: Discontinued
Active Ingredient: AMOXAPINE
Proprietary Name: ASENDIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 100MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N018021
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: LEDERLE LABORATORIES DIV AMERICAN CYANAMID CO
Marketing Status: Discontinued
Patent and Exclusivity Information
ASENDIN (AMOXAPINE)
Proprietary Name: ASENDIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 100MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N018021
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: LEDERLE LABORATORIES DIV AMERICAN CYANAMID CO
Marketing Status: Discontinued
Patent and Exclusivity Information
150MG
Marketing Status: Discontinued
Active Ingredient: AMOXAPINE
Proprietary Name: ASENDIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 150MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N018021
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: LEDERLE LABORATORIES DIV AMERICAN CYANAMID CO
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: ASENDIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 150MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N018021
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: LEDERLE LABORATORIES DIV AMERICAN CYANAMID CO
Marketing Status: Discontinued
Patent and Exclusivity Information